Lilly granted Cymbalta marketing extension

  • Wed, 07/11/2012 - 11:32am

The U.S. Food and Drug Administration granted Eli Lilly & Co. six more months to market the Cymbalta.

Canada adds heart warnings to Lexapro labels

  • Mon, 05/07/2012 - 4:09pm

Serotonin reuptake inhibitor Lexapro, or Cipralex, as it’s marketed in Canada, may cause heart rhythm problems. According to Health Canada, risk increases as dosage increases.

Consumer Drug Report

FDA approves first generic Lexapro

Yesterday, the Food and Drug Administration approved the first generic Lexapro (escitalopram tablets) to treat

SSRI Birth Defect Lawsuit - Consumer Drug Report

Birth defects caused by antidepressants provoke lawsuit

Many researchers debate whether it is safe for women to take antidepressants during pregnancy.